News Release

Gold Standard/Elsevier promotes medication safety and compliance via New MEDcounselor languages

Consumer medication information in 12 foreign languages

Business Announcement

Elsevier

TAMPA, FL – August 23, 2010 – Gold Standard/Elsevier, a leading developer of drug information and medication management solutions, announced today the launch of MEDcounselor Languages, a module that provides trusted MEDcounselor consumer medication information in 12 foreign languages. The new MEDcounselor Languages will enable healthcare providers to help non-English speaking patients better understand their drug therapy, take their medications safely, and avoid potentially harmful errors.

Based on state regulations and customer requests, the new languages offered within MEDcounselor Languages include Arabic, Bengali, Chinese, Creole (Haitian), French, Japanese, Italian, Korean, Polish, Russian, Tagalog and Vietnamese - along with currently available Spanish and English. Additional languages will be available in 2011.

"MEDcounselor Languages help pharmacies and health systems meet the needs of culturally diverse populations while fulfilling government requirements and meaningful use criteria for Language Access Services," said Marianne Messer, President of Gold Standard. "By employing the power of MEDcounselor Languages, providers can enhance the care they provide, promote medication knowledge, compliance and safety, and help patients and their families to achieve better personal healthcare management."

Providers can experience MEDcounselor Languages by joining representatives from Gold Standard (booth #514) at the National Association of Chain Drug Stores' Pharmacy and Technology Conference (NACDS), Aug. 28-31, 2010, in San Diego, California.

MEDcounselor Languages are available as an added module to Gold Standard's Clinical Pharmacology, a point-of-care drug reference, and Alchemy, an integrated drug database and decision support engine.

MEDcounselor Languages offers peer-reviewed content on the most frequently used U.S. prescription and over-the-counter drugs (such as medication uses, interactions and side effects), printable patient handouts, and compliance with national standards for Consumer Medication Information (CMI).

###

For more information on MEDcounselor Languages and related modules, please call +1 866-417-9150 or email goldstandard@elsevier.com.

About Gold Standard/Elsevier Based in Tampa, FL, Gold Standard/Elsevier uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Gold Standard/Elsevier solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To learn more about Gold Standard/Elsevier, visit www.goldstandard.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.